Functional Lipid Nanosystems in Cancer
Herausgeber: Lopes, Carla M.; Real Oliveira, Maria Elisabete C. D.; Lúcio, Marlene
Functional Lipid Nanosystems in Cancer
Herausgeber: Lopes, Carla M.; Real Oliveira, Maria Elisabete C. D.; Lúcio, Marlene
- Gebundenes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
This book compiles the research on the use of functional lipid nanosystems that combine different strategies in one single nanosystem to enhance overall cancer treatment. Besides providing an overview of the current functional nanosystem strategies, it also offers researchers essential theoretical background on cancer.
This book compiles the research on the use of functional lipid nanosystems that combine different strategies in one single nanosystem to enhance overall cancer treatment. Besides providing an overview of the current functional nanosystem strategies, it also offers researchers essential theoretical background on cancer.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Produktdetails
- Produktdetails
- Verlag: Jenny Stanford Publishing
- Seitenzahl: 714
- Erscheinungstermin: 30. November 2021
- Englisch
- Abmessung: 235mm x 157mm x 42mm
- Gewicht: 1169g
- ISBN-13: 9789814877268
- ISBN-10: 9814877263
- Artikelnr.: 60002312
- Verlag: Jenny Stanford Publishing
- Seitenzahl: 714
- Erscheinungstermin: 30. November 2021
- Englisch
- Abmessung: 235mm x 157mm x 42mm
- Gewicht: 1169g
- ISBN-13: 9789814877268
- ISBN-10: 9814877263
- Artikelnr.: 60002312
Marlene Lúcio, PharmD, PhD in Pharmaceutical Chemistry, is a researcher at the University of Minho, Portugal. She is recepient of the European Young Chemist Award for her outstanding contribution to research in life sciences. Since then, she has been developing lipid-based and hybrid nanosystems for several therapeutic applications. Carla M. Lopes, PharmD, PhD in Pharmaceutical Technology, is an assistant professor at Fernando Pessoa University, Portugal. She has done scientific consulting for health companies and has more than 10 years of experience in the development of lipid-based nanocarriers for targeting the delivery of bioactive compounds. M. Elisabete C. D. Real Oliveira, PhD in Physics, is an associate professor with habilitation at the Physics Department of the University of Minho. She has over 10 years of experience in the development of liposomal nanosystems for biological applications, namely cancer cell transfection, and siRNA silencing therapy in cancer.
Part 1: General Aspects of Cancer Pathology and Treament Options 1.
Physiological Barriers in Cancer: A Challenge to Be Overcome 2. Cancer
Chemotherapy, Bioactive Compounds, and Immunotherapy Part 2: General
Aspects of Functional Lipid Nanotherapy 3. General Aspects of a
Multifunctional Nanosystem Part 3: Multifunctional Lipid Nanosystems for
Cancer: Research Highlights 4. Co-delivery of Anticancer Therapeutics via
Lipid-Based Nanoscale Delivery Systems 5. Lipid-Based Nanocarriers for
Co-delivery of Anticancer Drugs and Natural Compounds 6. Co-delivery of
Anticancer Drug and Adjuvant Agents 7. Hybrid Nanosystems Composed by Lipid
and Polymer Materials 8. Lipid Nanosystems: Targeted Nano-delivery of
Therapeutic Agents in Treatment of Cancer 9. Monoclonal Antibody Ligands
for Liposomes Functionalization: Immunoliposomes Formulation and Clinical
Status 10. Active Targeting for Tumor Microenvironment: Integrin Binding
Peptides 11. Targeting Liposomes to Metastatic Tumors with Antibodies
Specific for VCAM-1 12. Active Targeting: Mitochondria-Targeting Signal
Peptides 13. Recent Developments of Light: Triggered Liposome Nanosystems
for Cancer Treatments 14. Ultrasound-Responsive Nanosystems 15. Lipid-Based
Nanosystems for Gene and Drug Co-delivery in Cancer Therapy 16. The
Therapeutical Window of Light: Modulating Receptor Proteins and Metabolic
Pathways with Light and Its Importance for Disease Control 17. Magnetic
Lipid-Based Nanosystems for Combined Therapy of Cancer
Physiological Barriers in Cancer: A Challenge to Be Overcome 2. Cancer
Chemotherapy, Bioactive Compounds, and Immunotherapy Part 2: General
Aspects of Functional Lipid Nanotherapy 3. General Aspects of a
Multifunctional Nanosystem Part 3: Multifunctional Lipid Nanosystems for
Cancer: Research Highlights 4. Co-delivery of Anticancer Therapeutics via
Lipid-Based Nanoscale Delivery Systems 5. Lipid-Based Nanocarriers for
Co-delivery of Anticancer Drugs and Natural Compounds 6. Co-delivery of
Anticancer Drug and Adjuvant Agents 7. Hybrid Nanosystems Composed by Lipid
and Polymer Materials 8. Lipid Nanosystems: Targeted Nano-delivery of
Therapeutic Agents in Treatment of Cancer 9. Monoclonal Antibody Ligands
for Liposomes Functionalization: Immunoliposomes Formulation and Clinical
Status 10. Active Targeting for Tumor Microenvironment: Integrin Binding
Peptides 11. Targeting Liposomes to Metastatic Tumors with Antibodies
Specific for VCAM-1 12. Active Targeting: Mitochondria-Targeting Signal
Peptides 13. Recent Developments of Light: Triggered Liposome Nanosystems
for Cancer Treatments 14. Ultrasound-Responsive Nanosystems 15. Lipid-Based
Nanosystems for Gene and Drug Co-delivery in Cancer Therapy 16. The
Therapeutical Window of Light: Modulating Receptor Proteins and Metabolic
Pathways with Light and Its Importance for Disease Control 17. Magnetic
Lipid-Based Nanosystems for Combined Therapy of Cancer
Part 1: General Aspects of Cancer Pathology and Treament Options 1.
Physiological Barriers in Cancer: A Challenge to Be Overcome 2. Cancer
Chemotherapy, Bioactive Compounds, and Immunotherapy Part 2: General
Aspects of Functional Lipid Nanotherapy 3. General Aspects of a
Multifunctional Nanosystem Part 3: Multifunctional Lipid Nanosystems for
Cancer: Research Highlights 4. Co-delivery of Anticancer Therapeutics via
Lipid-Based Nanoscale Delivery Systems 5. Lipid-Based Nanocarriers for
Co-delivery of Anticancer Drugs and Natural Compounds 6. Co-delivery of
Anticancer Drug and Adjuvant Agents 7. Hybrid Nanosystems Composed by Lipid
and Polymer Materials 8. Lipid Nanosystems: Targeted Nano-delivery of
Therapeutic Agents in Treatment of Cancer 9. Monoclonal Antibody Ligands
for Liposomes Functionalization: Immunoliposomes Formulation and Clinical
Status 10. Active Targeting for Tumor Microenvironment: Integrin Binding
Peptides 11. Targeting Liposomes to Metastatic Tumors with Antibodies
Specific for VCAM-1 12. Active Targeting: Mitochondria-Targeting Signal
Peptides 13. Recent Developments of Light: Triggered Liposome Nanosystems
for Cancer Treatments 14. Ultrasound-Responsive Nanosystems 15. Lipid-Based
Nanosystems for Gene and Drug Co-delivery in Cancer Therapy 16. The
Therapeutical Window of Light: Modulating Receptor Proteins and Metabolic
Pathways with Light and Its Importance for Disease Control 17. Magnetic
Lipid-Based Nanosystems for Combined Therapy of Cancer
Physiological Barriers in Cancer: A Challenge to Be Overcome 2. Cancer
Chemotherapy, Bioactive Compounds, and Immunotherapy Part 2: General
Aspects of Functional Lipid Nanotherapy 3. General Aspects of a
Multifunctional Nanosystem Part 3: Multifunctional Lipid Nanosystems for
Cancer: Research Highlights 4. Co-delivery of Anticancer Therapeutics via
Lipid-Based Nanoscale Delivery Systems 5. Lipid-Based Nanocarriers for
Co-delivery of Anticancer Drugs and Natural Compounds 6. Co-delivery of
Anticancer Drug and Adjuvant Agents 7. Hybrid Nanosystems Composed by Lipid
and Polymer Materials 8. Lipid Nanosystems: Targeted Nano-delivery of
Therapeutic Agents in Treatment of Cancer 9. Monoclonal Antibody Ligands
for Liposomes Functionalization: Immunoliposomes Formulation and Clinical
Status 10. Active Targeting for Tumor Microenvironment: Integrin Binding
Peptides 11. Targeting Liposomes to Metastatic Tumors with Antibodies
Specific for VCAM-1 12. Active Targeting: Mitochondria-Targeting Signal
Peptides 13. Recent Developments of Light: Triggered Liposome Nanosystems
for Cancer Treatments 14. Ultrasound-Responsive Nanosystems 15. Lipid-Based
Nanosystems for Gene and Drug Co-delivery in Cancer Therapy 16. The
Therapeutical Window of Light: Modulating Receptor Proteins and Metabolic
Pathways with Light and Its Importance for Disease Control 17. Magnetic
Lipid-Based Nanosystems for Combined Therapy of Cancer